NICE has published 4 new rapid guidelines on the active management of patients with suspected and confirmed COVID-19, and in patients without COVID-19. The guidelines have been designed to maximise the safety of patients whilst enabling services to make the best use of NHS resources.
As COVID-19 becomes more prevalent in the community, pneumonia is more likely to be caused by the COVID-19 virus than bacteria. Viral pneumonia will not respond to the use of antibiotics, therefore, they should only be offered if bacteria are the likely cause, it is unclear whether the cause is bacterial or viral and symptoms are more concerning or the person is at high risk of developing complications.
People should seek medical help without delay if their symptoms don’t improve or worsen rapidly, whether they have been given an antibiotic or not.
When possible, clinicians should discuss the risks, benefits and possible likely outcomes of treatment options with patients with COVID-19, and their families and carers, so that they can express their preferences about their treatment.
© NICE 2020 COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community. Available from the NICE website by clicking here. All rights reserved. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication. This guidance is published under the NICE-UK open content licence. You can access this licence by clicking here. The information above was correct at the time of publishing. This information is approved for use in the UK only.
Click here to read the Pharmacy in Practice Disclaimer. Click here to read your responsibility in regard to using NICE guidelines.